1607793-29-2
1607793-29-2 structure
- Name: Faricimab
- Chemical Name: Faricimab
- CAS Number: 1607793-29-2
- Molecular Formula:
- Molecular Weight:
- Catalog: Signaling Pathways Protein Tyrosine Kinase/RTK VEGFR
- Create Date: 2022-08-12 12:18:38
- Modify Date: 2025-08-25 12:35:20
-
Faricimab is a bispecific antibody targeting angiopoietin-2 and vascular endothelial growth factor-A (VEGF-A). Faricimab can be used for diabetic macular edema (DME) research[1].
| Name | Faricimab |
|---|
| Description | Faricimab is a bispecific antibody targeting angiopoietin-2 and vascular endothelial growth factor-A (VEGF-A). Faricimab can be used for diabetic macular edema (DME) research[1]. |
|---|---|
| Related Catalog | |
| Target |
Angiopoietin-2, VEGF-A[1] |
| References |
| No Any Chemical & Physical Properties |